[Medlife]12(S)-HETrE(solution)|72710-10-2

Medlife小分子 2023-09-21
简介:12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA). 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.英文名称:12(S)-HETrE

简介:12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA). 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.

12(S)-HETrE物理化学性质:

密度1.0±0.1 g/cm3
沸点487.4±33.0 °C at 760 mmHg
分子式C20H34O3
分子量322.482
闪点262.7±21.9 °C
精确质量322.250793
LogP5.94
蒸汽压0.0±2.8 mmHg at 25°C
折射率1.502

12(S)-HETrE详细介绍:

英文名称:12(S)-HETrE(solution)
英文别名:12(S)-HETrE;12S-HETrE;Q27163000
CAS号:72710-10-2
分子式:C20H34O3
分子量:322.48
详细描述12(S)-HETrE


Medlife品牌是国内知名的小分子化合物品牌,致力于信号通路、抑制剂、激动剂等产品的研发及产品供应服务,同时还可提供重组蛋白、植提、寡核苷酸等系列的产品。

本文引用地址:https://www.canspec.cn/product/899363.html


版权声明 本文地址:http://www.bioyun.cc/article/qianyan/Medlife1/945.html
1.产品咨询热线:4006087598;技术支持:www.canspec.cn ;产品赋能:www.perfemiker.cn 小分子专家:www.med-life.cn
2.文章若无特殊说明,均属本站原创,若转载文章请于作者联系。
3.本站除部分作品系原创外,其余均来自网络或其它渠道,本站保留其原作者的著作权!如有侵权,请与站长联系!
抗链霉亲和素抗体